A University of Central Florida team has designed a nanostructured optical sensor that for the first time can efficiently detect molecular chirality—a property of molecular spatial twist that defines its biochemical properties.
Determining chirality is critical for new drug development.
Think of molecules as having little hands. They are not identical, but they serve almost undistinguishable functions. You can grip, pinch, punch and open your hands, regardless of whether you use your left or right hand. But when you get to some functions, such as writing, it matters if you are right-handed or left-handed.
Scientists have struggled to determine if molecules have unique left- or right-hand functions because their physical attributes such as length, weight, density, elasticity, etc. appear to be identical.
UCF's NanoScience Technology Center Associate Professor Debashis Chanda and Ph.D. student Abraham Vazquez-Guardado have figured out a unique way to do it. The interaction between light and the specially designed nanostructure they built creates a strong chiral light field—called superchiral light. Such a nanostructure does not have geometrical chirality yet it creates two opposite light chirality (left or right) on demand. When light and matter's chirality match, just as hand-shaking with our right hand, successful identification happens.
Therefore, this rotating light field has the ability to probe and identify any chiral molecule like drugs, proteins or DNAs. The light field lets scientist see the tiny hands, so to speak.
"Chirality detection is vital in the drug-development industry, where newly synthesized chiral drugs also have two-handed strands and always form with the same likeliness during the synthesis process," Chanda said. "But while one chiral strand constitutes the active element in the drug, its opposite can turn out to be toxic or render detrimental side effects. Consequently, pharmacological and toxicological characterization of chirality plays a crucial role in the pharmaceutical drug industry and FDA approval process."
By being able to detect chirality at this level, scientists will have a better way to identify what may be causing bad side effects or perhaps finding places to upload life-saving drugs.
In this preliminary study, the UCF team demonstrated chiral molecule-detection sensitivity that is four times higher compared to the conventional technique, but without the extensive and tedious sample preparation and at much lower sample volume.
The single optical element thin-film chirality sensor, when fabricated based on low cost and large-area nanoimprinting technique, will immensely benefit drug design and protein-conformation identification, both of paramount importance in treating and understanding several diseases, Chanda added.
provided by University of Central Florida.